NEXGEL, Inc.
NEXGEL, Inc. (NXGLW) Stock Overview
Explore NEXGEL, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
16.4M
P/E Ratio
-6.32
EPS (TTM)
$-1.39
ROE
-0.63%
NXGLW Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of NEXGEL, Inc. (NXGLW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $1.27.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -6.32 and a market capitalization of 16.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. It provides facemasks, undereye patches, blister shield foot care, hexagel, cracked heel repair patches, and fever patch. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was founded in 1997 and is based in Langhorne, Pennsylvania.
Adam R. Levy
19
2150 Cabot Boulevard West, Langhorne, PA
1970